Cornerstone Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
2,591
+15
| +0.6% | +$11.7K | 0.22% | 64 |
|
|
2025
Q1 | $2M | Buy |
2,576
+45
| +2% | +$34.9K | 0.23% | 64 |
|
|
2024
Q4 | $2.14M | Sell |
2,531
-14
| -0.6% | -$11.8K | 0.24% | 63 |
|
|
2024
Q3 | $2.25M | Buy |
2,545
+14
| +0.6% | +$12.4K | 0.3% | 60 |
|
|
2024
Q2 | $2.29M | Buy |
2,531
+94
| +4% | +$85.1K | 0.32% | 56 |
|
|
2024
Q1 | $1.9M | Buy |
2,437
+496
| +26% | +$386K | 0.27% | 61 |
|
|
2023
Q4 | $1.13M | Buy |
1,941
+209
| +12% | +$122K | 0.18% | 75 |
|
|
2023
Q3 | $931K | Buy |
1,732
+50
| +3% | +$26.9K | 0.16% | 84 |
|
|
2023
Q2 | $789K | Buy |
1,682
+35
| +2% | +$16.4K | 0.14% | 97 |
|
|
2023
Q1 | $566K | Buy |
1,647
+162
| +11% | +$55.6K | 0.1% | 122 |
|
|
2022
Q4 | $543K | Buy |
1,485
+317
| +27% | +$116K | 0.11% | 121 |
|
|
2022
Q3 | $378K | Hold |
1,168
| – | – | 0.08% | 135 |
|
|
2022
Q2 | $379K | Sell |
1,168
-1,556
| -57% | -$505K | 0.09% | 133 |
|
|
2022
Q1 | $780K | Buy |
2,724
+738
| +37% | +$211K | 0.12% | 132 |
|
|
2021
Q4 | $549K | Sell |
1,986
-985
| -33% | -$272K | 0.08% | 168 |
|
|
2021
Q3 | $686K | Hold |
2,971
| – | – | 0.11% | 143 |
|
|
2021
Q2 | $681K | Hold |
2,971
| – | – | 0.11% | 136 |
|
|
2021
Q1 | $556K | Buy |
2,971
+1,100
| +59% | +$206K | 0.11% | 143 |
|
|
2020
Q4 | $316K | Sell |
1,871
-84
| -4% | -$14.2K | 0.06% | 168 |
|
|
2020
Q3 | $289K | Hold |
1,955
| – | – | 0.07% | 153 |
|
|
2020
Q2 | $321K | Buy |
1,955
+200
| +11% | +$32.8K | 0.08% | 137 |
|
|
2020
Q1 | $243K | Hold |
1,755
| – | – | 0.07% | 135 |
|
|
2019
Q4 | $231K | Buy |
+1,755
| New | +$231K | 0.05% | 153 |
|